Hitting A Moving Target: Teva’s Dethlefs Discusses US Complex Generics

Lack Of Clarity Over FDA Expectations And Mid-Cycle Changes Add To Challenges

 
• By David Wallace
  
Sven Dethlefs of Teva
Teva’s Sven Dethlefs talks about the challenges of bringing complex generics to market • Source: Teva
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products